BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gurzu S, Kadar Z, Sugimura H, Orlowska J, Bara T, Bara T, Szederjesi J, Jung I. Maspin-related Orchestration of Aggressiveness of Gastric Cancer. Appl Immunohistochem Mol Morphol. 2016;24:326-336. [PMID: 26067133 DOI: 10.1097/pai.0000000000000189] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Banias L, Jung I, Gurzu S. Subcellular expression of maspin – from normal tissue to tumor cells. World J Meta-Anal 2019; 7(4): 142-155 [DOI: 10.13105/wjma.v7.i4.142] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Kovacs Z, Jung I, Szalman K, Banias L, Bara TJ, Gurzu S. Interaction of arylsulfatases A and B with maspin: A possible explanation for dysregulation of tumor cell metabolism and invasive potential of colorectal cancer. World J Clin Cases 2019; 7(23): 3990-4003 [PMID: 31832401 DOI: 10.12998/wjcc.v7.i23.3990] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chen D, Xu L, Li X, Chu Y, Jiang M, Xu B, Zhao M, Wang W, Wang H, Kang H, Wang K, Wu K, Liang J, Ren G. Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer. Cell Death Dis 2018;9:998. [PMID: 30250066 DOI: 10.1038/s41419-018-1031-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gurzu S, Jung I. Subcellular Expression of Maspin in Colorectal Cancer: Friend or Foe. Cancers (Basel) 2021;13:366. [PMID: 33498377 DOI: 10.3390/cancers13030366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lu M, Yang Z, Feng Q, Yu M, Zhang Y, Mao C, Shen L, Tang J. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients. Medicine (Baltimore) 2016;95:e4052. [PMID: 27399088 DOI: 10.1097/MD.0000000000004052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
6 Zheng HC, Gong BC. The roles of maspin expression in gastric cancer: a meta- and bioinformatics analysis. Oncotarget. 2017;8:66476-66490. [PMID: 29029529 DOI: 10.18632/oncotarget.20192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
7 Zhou L, Li W, Cai S, Yang C, Liu Y, Lin Z. Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell: Results from the surveillance, epidemiology, and end results database. Medicine (Baltimore) 2019;98:e17367. [PMID: 31577736 DOI: 10.1097/MD.0000000000017367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Turdean SG, Gurzu S, Jung I, Neagoe RM, Sala D. Unexpected maspin immunoreactivity in Merkel cell carcinoma. Diagn Pathol. 2015;10:206. [PMID: 26607425 DOI: 10.1186/s13000-015-0437-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
9 Gurzu S, Jung I, Sugimura H, Stefan-van Staden RI, Yamada H, Natsume H, Iwashita Y, Szodorai R, Szederjesi J. Maspin subcellular expression in wild-type and mutant TP53 gastric cancers. World J Gastrointest Oncol 2020; 12(7): 741-755 [PMID: 32864042 DOI: 10.4251/wjgo.v12.i7.741] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Gurzu S, Orlowska J, Sugimura H, Bara T, Szentirmay Z, Januszewicz W, Bara T Jr, Szederjesi J, Jung I. Immunohistochemical features and staging of early gastric cancer. Arch Med Sci 2017;13:1373-82. [PMID: 29181068 DOI: 10.5114/aoms.2016.58665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]